LLMpediaThe first transparent, open encyclopedia generated by LLMs

Elixir Sulfanilamide

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 40 → Dedup 19 → NER 4 → Enqueued 4
1. Extracted40
2. After dedup19 (None)
3. After NER4 (None)
Rejected: 15 (not NE: 15)
4. Enqueued4 (None)
Elixir Sulfanilamide
IUPAC name4-Aminobenzenesulfonamide
CAS number63-74-1
PubChem5333
ChemSpider5142
UNII21240MF57M
DrugBankDB00259
ChEBI35358
ChEMBL504
ATC prefixJ01
ATC suffixEB06
Synonymspara-aminobenzenesulfonamide

Elixir Sulfanilamide was a toxic preparation of the sulfanilamide antibiotic that caused a mass poisoning in the United States in 1937. Marketed by the S. E. Massengill Company of Bristol, Tennessee, the liquid formulation used diethylene glycol as a solvent, a substance then unknown to be highly poisonous to humans. The resulting disaster, which killed over 100 people, became a pivotal catalyst for major reforms in American drug safety law, most notably the passage of the Federal Food, Drug, and Cosmetic Act of 1938.

Background and development

In the mid-1930s, sulfanilamide, a pioneering sulfonamide antibacterial drug, was revolutionizing the treatment of infections like streptococcal diseases and meningitis. The drug was initially available only in powder or tablet form. Seeking to create a more palatable liquid version for pediatric and adult patients who had difficulty swallowing pills, the S. E. Massengill Company directed its chief chemist, Harold Cole Watkins, to develop an elixir. Without conducting any toxicity studies, Watkins dissolved sulfanilamide in diethylene glycol, a sweet-tasting industrial solvent commonly used in antifreeze and lacquers, and added raspberry flavoring and caramel coloring. The company's quality control tests checked only for appearance, flavor, and fragrance, not safety, as no law at the time required such testing before marketing.

Mass poisoning incident

Beginning in September 1937, the S. E. Massengill Company distributed 240 gallons of the product across the nation. Physicians soon began reporting severe and fatal reactions in patients, primarily presenting with acute kidney failure characterized by anuria, severe pain, convulsions, and coma. The American Medical Association and the Food and Drug Administration, then led by Walter G. Campbell, launched urgent investigations. FDA inspectors, including the famed agent George P. Larrick, tracked down shipments through a massive manhunt, often racing ahead of the company's own recall telegrams. By the end of the episode, at least 107 people, many of them children, had died from ethylene glycol poisoning after ingesting the elixir.

Public and regulatory response

Public outrage was immense, fueled by extensive coverage in newspapers like The New York Times and advocacy from figures like Eleanor Roosevelt. The Food and Drug Administration could only prosecute the manufacturer on a technicality—misbranding, as the term "elixir" implied an alcoholic solution, which this was not—under the outdated Pure Food and Drug Act of 1906. The company's president, Samuel Evans Massengill, famously stated, "My chemists and I deeply regret the fatal results, but there was no error in the manufacture of the product. We have been supplying a legitimate professional demand and not once could have foreseen the unlooked-for results." This highlighted the profound legal deficiencies in consumer protection. The tragedy provided the final impetus for the long-debated Federal Food, Drug, and Cosmetic Act, which was signed into law by President Franklin D. Roosevelt in June 1938.

Aftermath and legacy

The new law fundamentally transformed the Food and Drug Administration, requiring pre-market safety testing for new drugs and mandating that labels include adequate directions for safe use. It also prohibited false therapeutic claims and gave the agency greater authority over factory inspections. The chemist Harold Cole Watkins died by suicide in 1939. The disaster remains a cornerstone case study in pharmacology, toxicology, and regulatory science, cited alongside later drug safety crises like those involving thalidomide and Vioxx. It established the modern principle that manufacturers bear the primary responsibility for proving a drug's safety before it can be sold to the public.

Chemical composition and properties

The lethal formulation consisted of approximately 10% (weight/volume) of the active pharmaceutical ingredient sulfanilamide, a white crystalline powder with the chemical name 4-aminobenzenesulfonamide. It was dissolved in 72% diethylene glycol, a colorless, odorless, sweet-tasting liquid with the formula C₄H₁₀O₃. The remaining components included water, flavoring, and coloring agents. In the human body, diethylene glycol is metabolized into 2-hydroxyethoxyacetic acid and diglycolic acid, which are potent nephrotoxins that cause fatal renal tubular necrosis and metabolic acidosis. This biochemical pathway was elucidated in subsequent toxicological investigations following the incident. Category:1937 in the United States Category:History of medicine in the United States Category:Poisoning Category:Pharmaceutical industry